Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patients with Waldenström macroglobulinemia have impaired platelet and coagulation function.

Autor: Brysland SA; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Talaulikar D; Department of Clinical Haematology, Canberra Health Services, Canberra, ACT, Australia.; School of Medicine and Psychology, The Australian National University, Canberra, ACT, Australia., Hicks SM; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Hearn JI; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Ali SA; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Maqbool MG; Department of Clinical Haematology, Canberra Health Services, Canberra, ACT, Australia., Mokoonlall M; Department of Clinical Haematology, Canberra Health Services, Canberra, ACT, Australia., Bhoopalan V; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Kaur A; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Thong YL; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Andrews RK; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Whisstock JC; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Melbourne, VIC, Australia., Crispin PJ; Department of Clinical Haematology, Canberra Health Services, Canberra, ACT, Australia.; School of Medicine and Psychology, The Australian National University, Canberra, ACT, Australia., Gardiner EE; Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.

Publikováno v: Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5542-5555.